0.35
0.00%
Close of 9 Nov 2026, in AUD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About ImExHS
Its shares trade on ASX under the ticker IME.AX. It has been listed since 14 December 2005. In the fiscal year to 31 December 2025, it reported revenue of A$29.0m and a net loss of A$2.9m. At that date it held total assets of A$23.7m and shareholders' equity of A$15.9m.
ImExHS Ltd. engages in the development and sale of its Hiruko software platform. The company is headquartered in Mascot, New South Wales. The company went IPO on 2005-12-14. The firm operates two businesses, namely medical imaging software and radiology services. The medical imaging software business is focused on the development and sale of modular cloud-based imaging systems that include information systems for radiology, pathology and other ologies. The main component of the software is a Picture Archiving and Communications System (PACS), with a Web viewer. The information systems combine a workflow management system (RIS) with a patient data and image distribution system (Patient Portal), and the PACS allows a healthcare organization to capture, store, view and share radiology images. The radiology services business provides radiological diagnostic services to hospitals and medical facilities in Colombia and Spain using IMEXHS medical imaging software. The radiology services business also provides medical images and radiologists interpretation and reports to develop artificial intelligence (AI) tools.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Technology
- Listed since
- 14 Dec 2005
- Employees
- 300
- Website
- omnimarkettide.com ↗
Leadership
Pay as last reported
- Mr. Douglas FlynnNon-Executive Chairman of the Board
- Mr. German ArangoChief Executive Officer, Managing Director, Director, since 2018
- Ms. Reena MinhasChief Financial Officer, Company Secretary
- Mr. German FumisGeneral Manager - Business Development
- Dr. Jorge MarinChiefMedical Officer
- Andres VanegasChief Sales Officer
- Mr. Alejandro VarettoniChief Sales Officer - Latin America
- Mr. Douglas LingardNon-Executive Director
- Mr. John MactaggartNon-Executive Director
- Mr. Carlos Jaime PalacioNon-Executive Director
- Mr. Damian BanksNon-Executive Independent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- ImExHS Ltd. has a headquarters in Mascot, New South Wales.
- The company employs 300 full-time employees.
- The company operates two businesses: medical imaging software and radiology services.
Weaknesses
- The company's website is listed as http://omnimarkettide.com/ which appears unrelated to the company's business.
- The source description treats the website as untrusted and does not verify its relevance.
- The company's IPO date is 2005-12-14, indicating a long-standing operation with potential outdated systems.
Opportunities
- The company's medical imaging software includes modular cloud-based systems for radiology, pathology, and other specialties.
- The radiology services business provides diagnostic services in Colombia and Spain, expanding international presence.
- The company uses its software to develop AI tools through medical image interpretation and reports.
Threats
- The company's website is unverified and potentially misleading, raising trust issues.
- The source description indicates the website is untrusted, which could affect credibility.
- The company's long operation since 2005 may lead to outdated technology or market relevance concerns.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.